Next Article in Journal
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling
Previous Article in Journal
Neuroprotective Effects of the Neural-Induced Adipose-Derived Stem Cell Secretome against Rotenone-Induced Mitochondrial and Endoplasmic Reticulum Dysfunction
Previous Article in Special Issue
Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral 18FDG in Mice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 6
10.3390/ijms24065625
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Int. J. Mol. Sci. 2021, 22(19), 10643.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: La Sala et al. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643

by
Lucia La Sala
1,* and
Antonio E. Pontiroli
2
1
IRCCS MultiMedica, Lab of Diabetology and Dysmetabolic Disease, PST Via Fantoli, 16/15, 20138 Milan, Italy
2
Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milan, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(6), 5625; https://doi.org/10.3390/ijms24065625
Submission received: 20 July 2022 / Accepted: 9 October 2022 / Published: 15 March 2023
(This article belongs to the Special Issue Gut Hormone: From Molecular Mechanism to Clinical Aspects 2021)
Versions Notes
The authors would like to make corrections to the reference citations in the original article [1]. The author mistakenly deleted “reference 45” [2] during proofreading, adjusted some reference order, and renewed the original “reference 81 and 82” [3,4]. With this change, the order of some reference citations has been adjusted correspondingly. The corrected version of this literature review addresses errors in the numbering of citations that were introduced during the proofreading stage of submission.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. La Sala, L.; Pontiroli, A.E. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643. [Google Scholar] [CrossRef] [PubMed]
  2. Foa, P.P.; Weinstein, H.R.; Smith, J.A. Secretion of insulin and of a hyperglycemic substance studied by means of pancreatic-femoral cross-circulation experiments. Am. J. Physiol. 1949, 157, 197–204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Cherubini, V.; Rabbone, I.; Lombardo, F.; Mossetto, G.; Orsini Federici, M.; Nicolucci, A. Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes in the real-life, post-Diabetes Control and Complications Trial setting: A systematic review. Pediatr Diabetes 2019, 20, 678–692. [Google Scholar] [CrossRef] [PubMed]
  4. Wang, J.; Geiss, L.S.; Williams, D.E.; Gregg, E.W. Trends in Emergency Department Visit Rates for Hypoglycemia and Hy-perglycemic Crisis among Adults with Diabetes, United States, 2006–2011. PLoS ONE 2015, 10, e0134917. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

La Sala, L.; Pontiroli, A.E. Correction: La Sala et al. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643. Int. J. Mol. Sci. 2023, 24, 5625. https://doi.org/10.3390/ijms24065625

AMA Style

La Sala L, Pontiroli AE. Correction: La Sala et al. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643. International Journal of Molecular Sciences. 2023; 24(6):5625. https://doi.org/10.3390/ijms24065625

Chicago/Turabian Style

La Sala, Lucia, and Antonio E. Pontiroli. 2023. "Correction: La Sala et al. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643" International Journal of Molecular Sciences 24, no. 6: 5625. https://doi.org/10.3390/ijms24065625

APA Style

La Sala, L., & Pontiroli, A. E. (2023). Correction: La Sala et al. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643. International Journal of Molecular Sciences, 24(6), 5625. https://doi.org/10.3390/ijms24065625

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop